ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,37%
Bitcoin
60.972,19
0,29%
Brent Oil
82,585
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Concert Pharmaceuticals Inc (CNCE)

  7. Concert Pharmaceuticals Inc (CNCE) Notícias

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CNCE
DataHoraFonteTítuloCódigoCompanhia
16/03/202310:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202307:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202313:58Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202313:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202311:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202311:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202311:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202309:00Business WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202319:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/02/202311:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202310:12Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CNCEConcert Pharmaceuticals Inc
02/02/202309:32Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CNCEConcert Pharmaceuticals Inc
01/02/202319:13Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202312:40Dow Jones NewsConcert Pharmaceuticals Shares Rally on Takeover by SunNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202310:47Dow Jones NewsSun Pharmaceutical to Buy Concert Pharmaceuticals For Initial $576 MillionNASDAQ:CNCEConcert Pharmaceuticals Inc
19/01/202310:00Business WireSun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
09/12/202220:25TipRanksJonesTrading Keeps Their Buy Rating on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
22/11/202208:25TipRanksH.C. Wainwright Remains a Buy on Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
21/11/202209:00Business WireConcert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair ResearchNASDAQ:CNCEConcert Pharmaceuticals Inc
09/11/202209:00Business WireConcert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/202208:25TipRanksConcert Pharma (CNCE) Gets a Buy from H.C. WainwrightNASDAQ:CNCEConcert Pharmaceuticals Inc
08/11/202200:25TipRanksConcert Pharma (CNCE) Receives a Buy from JonesTradingNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202214:05TipRanksConcert Pharma (CNCE) Gets a Buy from JMP SecuritiesNASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202209:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/11/202209:00Business WireConcert Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:CNCEConcert Pharmaceuticals Inc
31/10/202208:00Business WireConcert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022NASDAQ:CNCEConcert Pharmaceuticals Inc
12/09/202222:05TipRanksJonesTrading Sticks to Their Buy Rating for Concert Pharma (CNCE)NASDAQ:CNCEConcert Pharmaceuticals Inc
10/09/202206:30Business WireConcert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV CongressNASDAQ:CNCEConcert Pharmaceuticals Inc
06/09/202208:00Business WireConcert Pharmaceuticals to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
01/09/202208:00Business WireBridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CNCE

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados